Merck in Negotiations to Acquire Revolution Medicines for Up to $32 Billion
TL;DR Summary
Merck is in negotiations to acquire biotech firm Revolution Medicines, with the deal not yet finalized and other bidders potentially involved, causing Revolution's shares to rise.
- Merck in talks to buy biotech Revolution Medicines, FT reports Yahoo Finance
- Revolution Medicines takeout speculation spotlight shines on Merck & Co. FirstWord
- Merck in Talks to Buy Revolution Medicines Per Financial Times Report Yahoo Finance
- Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn Financial Times
- AbbVie denies media reports of talks to buy Revolution Medicines Reuters
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
0 min
vs 1 min read
Condensed
78%
119 → 26 words
Want the full story? Read the original article
Read on Yahoo Finance